Advance Translational Proteomics Research

The Seer Insights Translational Research Track supports investigators conducting proteomics research with a clear path toward improving understanding of human disease.

This track is designed for academic and translational researchers, particularly those without established in-house mass spectrometry proteomics capabilities, seeking to leverage deep, unbiased proteomic insights to advance studies in areas such as:

• Biomarker discovery
• Disease mechanism research
• Translational cohort studies
• Clinical research programs

Selected awardees will receive access to Seer’s Proteograph^® workflow through the Seer Technology Access Center (STAC), enabling high-depth proteomic analysis to support translational discovery.

What to Expect

Researchers are invited to submit a brief research proposal describing their study aims, experimental design, and how Seer’s proteomics technology will help address key scientific questions.

Proposals will be evaluated by a panel of scientific experts based on:

• Scientific merit
• Translational impact
• Alignment with Seer technology
• Experimental feasibility

The submission process is completed through a web-based application form and typically requires approximately 15–20 minutes to complete.

Proposals will undergo scientific review following the submission deadline, and one proposal will be selected for support through the 2026 Translational Research Track.

Program Support

Selected investigators will receive a service grant supporting translational proteomics research using Seer’s Proteograph workflow

Support provided through STAC includes:

• Access to Seer’s Proteograph^® workflow for deep proteomic profiling
• Processing and analysis of up to 160 samples
• State-of-the-art mass spectrometry analysis performed at STAC
• Bioinformatics support for study analysis and interpretation
• Opportunity to present findings at a Seer-sponsored scientific session

This support is intended to enable completion of a high-impact translational proteomics research that advances understanding of human health and disease.

Eligibility

Applicants must:

• Be affiliated with a recognized academic or research institution
• Propose a project with a clear translational research focus
• Demonstrate alignment between the study design and the capabilities of Seer’s Proteograph^® technology
• Submit compatible sample types including plasma, serum, and/or cerebrospinal fluid (CSF)
• Not have established internal mass spectrometry-based proteomics workflows as a primary research capability or method for generating proteomic data

Please review the Official Rules for more information.

Submit Your Research Proposal